News
-
AXA - Elimination of the dilutive impact of Shareplan 2026
-
AXA - Elimination de l'effet dilutif de l'opération Shareplan 2026
-
Disclosure of shares outstanding and voting rights - 05.10.2026
-
Déclaration nombre d'actions et droits de vote - 05.10.2026
-
LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
-
EV Nickel Announces Formation of Wholly Owned Subsidiary to Advance Nickel Bioleaching Technology and Canadian Nickel Supply Chain
-
NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
-
Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
-
Solitario CEO to Present at John Tumazos Very Independent Research, LLC
-
Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
-
Aperam update on Q3 2026 market & financial trends
-
Aperam update on Q3 2026 market & financial trends
-
Julius Baer Board of Directors announces two new Director nominations
-
Trading Update: Continued Weak Demand and Further Inflation-Driven Cost Increases - wienerberger Adjusts Full-Year Guidance
-
Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy